Molecular Biology and Therapeutics in Musculoskeletal Oncology (MBTMO) Research S

肌肉骨骼肿瘤学的分子生物学和治疗学 (MBTMO) 研究 S

• 批准号: 7541111
• 负责人: Regis J O'Keefe
• 金额: $ 1.6万
• 依托单位: AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-01 至 2009-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7541111
• 关键词: Academy; Advocate; American; Area; Arts; Chondrosarcoma; Clinical; Collaborations; Communities; Defect; Development; Disabled Persons; Disease; Disease susceptibility; Education; Ensure; Ewings sarcoma; Faculty; Foundations; Future; Genomics; Government; Health; Industry; Joints; Journals; Laboratory Research; Malignant Neoplasms; Medical; Medicine; Minority; Molecular Biology; Musculoskeletal; Operative Surgical Procedures; Orthopedics; Patient Care; Patients; Physicians; Provider; Publications; Recording of previous events; Research; Research Personnel; Resistance; Science; Screening procedure; Societies; Specialist; Surgeon; Techniques; Therapeutic; Tissues; Translating; Tumor Biology; Universities; Woman; base; biological research; bone; design; improved; interest; knowledge base; medical specialties; member; novel; oncology; osteosarcoma; sarcoma; symposium

DESCRIPTION (provided by applicant): The American Academy of Orthopaedic Surgeons (AAOS) strives to serve the orthopaedic profession, champion the interests of patients, and advance the highest quality musculoskeletal health. The AAOS is the preeminent provider of musculoskeletal education to orthopaedic surgeons and others in the world. The AAOS also serves as an advocate for improved patient care and informs the public about the science of orthopaedics. Founded at Northwestern University as a not-for-profit organization in 1933, the AAOS has grown from a small organization serving less than 500 members to the world's largest medical association of musculoskeletal specialists. The Academy now serves more than 30,000 members internationally. The AAOS has been involved with many outstanding researchers in the development and presentation of information on the "cutting edge" of orthopaedics. The AAOS Research Symposia represent a long history of collaboration between the Academy, governmental agencies, industry, specialty societies, the Orthopaedic Research and Education Foundation (OREF), the Orthopaedic Research Society (ORS), leading researchers, and clinicians. The annual research symposia are designed to define the knowledge base in a chosen topic area based on scientific evidence, to identify gaps in the knowledge base, and to outline future research opportunities. The symposia provide an opportunity for experts to exchange information and develop collaborative endeavors through scientific presentations and active discussion groups. The 2008 AAOS/ORS Molecular Biology and Therapeutics in Musculoskeletal Oncology (MBTMO) Research Symposium, September 25-27, 2008, will define the state-of-the-art as it pertains to musculoskeletal oncology and identify future research directions. Specifically, the MBTMO symposium will identify the current status of clinical and biological research and practice in important areas of musculoskeletal oncology, including Tumor Biology, Current Treatment/Limitations/Resistance to Treatment, Biologic Based Therapy for Osteosarcoma, Biologic Based Therapy for Ewing's Sarcoma, Biologic Based Therapy for Chondrosarcoma, Biologic Based Therapy for Soft Tissue Sarcoma , Genomic Screening Techniques for Disease Susceptibility and New Treatments, Novel Therapies/Strategies/Regulatory Issues, and Management of Tissue Defects and Metastatic Disease. The symposium will define needs and opportunities for translating laboratory research into clinical practice, stimulate the research agenda, and provide education to the musculoskeletal community, including practicing physicians and young investigators in the form of timely summary article publication through an existing relationship with the Journal of Bone and Joint Surgery (JBJS), on the AAOS website, and to cancer-specific organizations and groups. The symposium will promote interaction between stakeholders in the area of musculoskeletal medicine, industry and government. The MBTMO co-chairs ensure the inclusion of minorities, women, and persons with disabilities both as faculty and as invited guests.

描述（由申请人提供）：美国骨科医生学会（AAOS）致力于为骨科专业服务，维护患者的利益，并促进最高质量的肌肉骨骼健康。AAOS是世界上为矫形外科医生和其他人提供肌肉骨骼教育的杰出机构。AAOS还作为改善患者护理的倡导者，并向公众介绍骨科科学。AAOS于1933年在西北大学成立，是一个非营利组织，从一个服务不到500名成员的小组织发展成为世界上最大的肌肉骨骼专家医学协会。该学院目前在国际上为30，000多名成员提供服务。AAOS与许多杰出的研究人员一起参与了骨科“前沿”信息的开发和介绍。 AAOS研究研讨会代表了学院，政府机构，行业，专业协会，骨科研究和教育基金会（OREF），骨科研究学会（ORS），领先的研究人员和临床医生之间的长期合作历史。年度研究专题讨论会的目的是根据科学证据确定选定专题领域的知识库，查明知识库中的差距，并概述未来的研究机会。专题讨论会为专家们提供了一个机会，通过科学介绍和积极的讨论小组交流信息和开展合作。 2008年9月25日至27日举行的2008年AAOS/ORS肌肉骨骼肿瘤学分子生物学和治疗学（MBTMO）研究研讨会将定义与肌肉骨骼肿瘤学相关的最新技术，并确定未来的研究方向。具体而言，MBTMO研讨会将确定肌肉骨骼肿瘤学重要领域的临床和生物学研究与实践的现状，包括肿瘤生物学，当前治疗/限制/治疗抵抗，骨肉瘤的生物基础治疗，尤文肉瘤的生物基础治疗，软骨肉瘤的生物基础治疗，软组织肉瘤的生物基础治疗，疾病易感性和新疗法的基因组筛选技术，新疗法/策略/监管问题，以及组织缺陷和转移性疾病的管理。研讨会将确定将实验室研究转化为临床实践的需求和机会，刺激研究议程，并为肌肉骨骼社区提供教育，包括执业医生和年轻的研究人员，通过与骨关节外科杂志（JBJS）的现有关系及时发表摘要文章，在AAOS网站上，以及癌症特定的组织和团体。该研讨会将促进肌肉骨骼医学领域的利益相关者、行业和政府之间的互动。MBTMO联合主席确保将少数民族，妇女和残疾人纳入教师和特邀嘉宾。